Uristat

Uristat

febuxostat

Manufacturer:

Healthcare Pharma

Distributor:

San Lwin Trading

Marketer:

San Lwin Trading
Concise Prescribing Info
Contents
Febuxostat
Indications/Uses
Chronic management of hyperuricemia in patients w/ gout.
Dosage/Direction for Use
40 mg once daily. If serum uric acid >6 mg/dL after 2 wk, 80 mg once daily.
Administration
May be taken with or without food: May be taken w/o regard to antacid use.
Contraindications
Patients being treated w/ azathioprine, mercaptopurine or theophylline.
Special Precautions
Do not discontinue treatment if gout flare occurs during treatment. Monitor liver function. Pregnancy & lactation. Childn <12 yr.
Adverse Reactions
Liver problems, nausea, gout flares, joint pain & rash.
Drug Interactions
Increased plasma conc of azathioprine, mercaptopurine or theophylline leading to severe toxicity.
MIMS Class
Hyperuricemia & Gout Preparations
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Presentation/Packing
Form
Uristat FC tab 40 mg
Packing/Price
1 × 30's
Form
Uristat FC tab 80 mg
Packing/Price
1 × 20's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in